roquinimex analogs (Fujisawa)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameroquinimex analogs (Fujisawa)
Drug Alias Namelinomide analogs (Fujisawa)FR-149470FR-137316
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseAutoimmune DiseasesNephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFujisawa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseAutoimmune DiseasesNephritis

Other Information

ATC CodeN/A
Related LinksN/A